Pharmaco - Press Releases

Date	Title	Company
09-Feb-2023	Invitation: Straumann Group 2022 full-year results webcast	Straumann Holding AG
09-Feb-2023	Biotest AG: Biotest significantly exceeds EBIT guidance 2022	Biotest AG
09-Feb-2023	Evotec and Related Sciences expand integrated drug discovery and development partnership	Evotec SE
08-Feb-2023	Lonza Prices CHF 300 Million Straight Bond with a 2.100% Coupon	Lonza Group AG
08-Feb-2023	Bayer Aktiengesellschaft: William N. Anderson to succeed Werner Baumann as Chairman of the Board of Management of Bayer AG	Bayer Aktiengesellschaft
08-Feb-2023	Availability of Sanofi’s Nexviadyme®▼(avalglucosidase alfa) provides NHS with new treatment for Pompe disease	Sanofi
08-Feb-2023	Sartorius Stedim Biotech SA: Board of Directors of Sartorius Stedim Biotech resolves to propose a dividend of 1.44 euros per share to the Annual Shareholders’ Meeting	Sartorius Stedim Biotech SA
08-Feb-2023	The new DUSA Shaker™ DTS 100i from Copley: For faster, safer, more repeatable inhaler testing	Copley Scientific
08-Feb-2023	BioSenic announces the approval and publication of the Prospectus for listing and admission to trading of the shares and subscription rights issued in the context of the capital increase by way of in kind contributions of Medsenic 51 percent participation	BioSenic
08-Feb-2023	NICE draft guidance does not recommend empagliflozin (Jardiance®) for treating symptomatic chronic heart failure with preserved or mildly reduced ejection fraction	Boehringer Ingelheim
08-Feb-2023	Santhera Concludes Agreement with French Authorities on Raxone® Reimbursement and Plans to Submit a Request for an Early Access Program for Vamorolone	Santhera
08-Feb-2023	Spinout develops open-source software for the pharmaceutical industry	Spinout OpenBioSim
08-Feb-2023	Major national testing centre to become anchor resident at PHTA	Clinical Immunology Service (CIS)
08-Feb-2023	Cell and Gene Therapy Catapult to play significant role in establishing one of the largest life sciences campuses in Europe	Cell and Gene Therapy Catapult
08-Feb-2023	Bayer donates 1.5 million euros for immediate aid to victims of devastating earthquakes in Türkiye and Syria	Bayer
08-Feb-2023	Sequana Medical announces the successful completion of pre-clinical studies with its second-generation DSR product for congestive heart failure	Sequana Medical
08-Feb-2023	InvestEU: EIB Agrees to a €18 Million Loan to Estonian Biotech Icosagen for Innovative R&D Technologies and New cGMP Production Facility	Icosagen AS
08-Feb-2023	InvestEU: EIB Agrees to a €18 Million Loan to Estonian Biotech Icosagen for Innovative R&D Technologies and New cGMP Production Facility	B3C newswire
08-Feb-2023	Spexis and SPRIM Global Investments (SGI) Announce Plans for Clinical Trial Partnership to Fund up to Half of the Projected Phase 3 Clinical Development Costs of ColiFin®	Spexis AG
08-Feb-2023	Relief Therapeutics Provides an Update on its Financing Strategy	Relief Therapeutics Holding SA